Category: Insider Activity

On September 9, 2019, Michael Bonney – Director of Sarepta Therapeutics, Inc. (SRPT)– purchased 2,000 shares of SRPT at $86.74. His out of pocket cost was $173,480.

On Sept. 5, 2019, Stephen Doberstein – SVP and Chief Scientific Officer of Nektar Therapeutics (NKTR) – purchased 15,000 shares of NKTR at $17.28. His out of pocket cost was $259,200.

On September 6, 2019, Franklin Myers – Chairman of the Board of Comfort Systems USA, Inc. (FIX) – purchased 5,000 shares of FIX at $38.00. His out of pocket cost was $190,000.

On August 30, 2019, John Miller – Director of Sally Beauty Holdings, Inc. (SBH) – purchased 40,500 shares of SBH at $12.21. His out of pocket cost was $494,554.

On August 30, 2019, Frank Jaehnert – Director of Briggs & Stratton Corporation (BGG)– purchased 40,000 shares of BGG at $4.39. His out of pocket cost was $175,680.

On August 28, 2019, Robert Holmes Swan – CEO of Intel Corporation (INTC) – purchased 10,918 shares of INTC at $45.70. His out of pocket cost was $498,953.

On August 27, 2019, Scott Toothaker – Director of Bar Harbor Bankshares (BHB)– purchased 5,371 shares of STBA at $21.63. His out of pocket cost was $116,175.

On Aug 27, 2019, John Timken – Director of The Timken Company (TKR) – purchased 5,000 shares of TKR at $38.04. His out of pocket cost was $190,216.

On Aug 23, 2019, Charles Bunch – Director of The PNC Financial Services Group, Inc. (PNC) – purchased 1,000 shares of STBA at $124.38. His out of pocket cost was $124,380.

On August 23, 2019, Scott Gottlieb (former FDA Commissioner) – Director of Pfizer Inc. (PFE) – purchased 3,000 shares of PFE at $34.72. His out of pocket cost was $104,160.